Literature DB >> 8411364

Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay.

S F Yu1, M L Linial.   

Abstract

We have constructed a BHK-21-derived indicator cell line containing a single integrated copy of the beta-galactosidase (beta-Gal) gene under control of the human foamy virus (HFV) long terminal repeat promoter (from -533 to +20). These foamy virus-activated beta-Gal expression (FAB) cells can be used in a quantitative assay to measure the infectious titer of HFV. Our results show that the FAB assay is 50 times more sensitive than determination of the virus titer by the end-point dilution method. Using the FAB assay, we have found that HFV can productively replicate in several erythroblastoid cell lines as well as in the Jurkat T-cell line. We have also examined the roles of bel2, bet, and bel3 in viral replication by constructing proviral HFV clones in which the reading frame of Bel2, Bet, or Bel3 is disrupted by placement of translation stop codons. Analysis of these mutants reveals that while the bel3 gene is not required for viral replication in vitro, mutations in the bel2 or bet gene decrease cell-free viral transmission approximately 10-fold.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8411364      PMCID: PMC238099     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

Review 1.  Spumaviruses: a group of complex retroviruses.

Authors:  R M Flügel
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

2.  Translational control of human cytomegalovirus gp48 expression.

Authors:  M R Schleiss; C R Degnin; A P Geballe
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  Characterization of the transcriptional trans activator of human foamy retrovirus.

Authors:  A Keller; K M Partin; M Löchelt; H Bannert; R M Flügel; B R Cullen
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  RNA dependent DNA polymerase in primate syncytium-forming (foamy) viruses.

Authors:  W P Parks; G J Todaro; E M Scolnick; S A Aaronson
Journal:  Nature       Date:  1971-01-22       Impact factor: 49.962

5.  An unusual virus in cultures from a human nasopharyngeal carcinoma.

Authors:  B G Achong; P W Mansell; M A Epstein; P Clifford
Journal:  J Natl Cancer Inst       Date:  1971-02       Impact factor: 13.506

6.  Fluorescence assay of foamy virus.

Authors:  W A Fleming; J K Clarke
Journal:  J Gen Virol       Date:  1970-02       Impact factor: 3.891

7.  Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes.

Authors:  K Bothe; A Aguzzi; H Lassmann; A Rethwilm; I Horak
Journal:  Science       Date:  1991-08-02       Impact factor: 47.728

8.  Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene.

Authors:  M Löchelt; H Zentgraf; R M Flügel
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

9.  Transcription factor AP-1 modulates the activity of the human foamy virus long terminal repeat.

Authors:  B Maurer; E Serfling; V ter Meulen; A Rethwilm
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein.

Authors:  B Guy; M Geist; K Dott; D Spehner; M P Kieny; J P Lecocq
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

View more
  63 in total

1.  An endoplasmic reticulum retrieval signal partitions human foamy virus maturation to intracytoplasmic membranes.

Authors:  P A Goepfert; K Shaw; G Wang; A Bansal; B H Edwards; M J Mulligan
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Biphasic DNA synthesis in spumaviruses.

Authors:  Olivier Delelis; Ali Saïb; Pierre Sonigo
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

3.  Role of the C terminus of foamy virus Gag in RNA packaging and Pol expression.

Authors:  Carolyn R Stenbak; Maxine L Linial
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

4.  Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.

Authors:  Grant Trobridge; David W Russell
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

5.  Foamy virus Pol protein expressed as a Gag-Pol fusion retains enzymatic activities, allowing for infectious virus production.

Authors:  Eun-Gyung Lee; Amber Sinicrope; Dana L Jackson; Shuyuarn F Yu; Maxine L Linial
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

6.  Foamy retrovirus integrase contains a Pol dimerization domain required for protease activation.

Authors:  Eun-Gyung Lee; Jacqueline Roy; Dana Jackson; Patrick Clark; Paul L Boyer; Stephen H Hughes; Maxine L Linial
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

7.  Restriction of foamy viruses by APOBEC cytidine deaminases.

Authors:  Frédéric Delebecque; Rodolphe Suspène; Sara Calattini; Nicoletta Casartelli; Ali Saïb; Alain Froment; Simon Wain-Hobson; Antoine Gessain; Jean-Pierre Vartanian; Olivier Schwartz
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

8.  Identification of novel, highly expressed retroviral microRNAs in cells infected by bovine foamy virus.

Authors:  Adam W Whisnant; Timo Kehl; Qiuying Bao; Magdalena Materniak; Jacek Kuzmak; Martin Löchelt; Bryan R Cullen
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

9.  Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein.

Authors:  J Konvalinka; M Löchelt; H Zentgraf; R M Flügel; H G Kräusslich
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Sensitive assays for simian foamy viruses reveal a high prevalence of infection in commensal, free-ranging Asian monkeys.

Authors:  Lisa Jones-Engel; Katherine A Steinkraus; Shannon M Murray; Gregory A Engel; Richard Grant; Nantiya Aggimarangsee; Benjamin P Y-H Lee; Cynthia May; Michael A Schillaci; Chaleamchat Somgird; Tulyawat Sutthipat; Lucia Vojtech; JianYuan Zhao; Maxine L Linial
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.